# ğŸ’Š Geriatric Digoxin PK Digital Twin
### An Explainable, Patient-Specific Pharmacokinetic Simulator for Precision Geriatric Dosing

## ğŸ“– Overview
This project is a fully client-side, web-based **Explainable Pharmacokinetic Digital Twin** that simulates how **Digoxin** behaves in:
- **Normal adults**
- **Frail geriatric patients** (reduced renal function, low body weight, sarcopenia)

Digoxin has a **Narrow Therapeutic Index (NTI)**. Small concentration increases can cause toxicity (arrhythmia, bradycardia, visual disturbances). The simulator demonstrates why **population-based dosing fails** in older adults and why **individualized PK** is essential.

ğŸ‘‰ **Live Demo:** *(Add link)*

---

## ğŸ§  Core Idea
> **One dose does not fit all.**

This tool provides:
- Individualized PK parameters
- Concentrationâ€“time curves
- Steady-state metrics
- Explainable clinical insights
- Side-by-side comparison with healthy adults

---

## ğŸ’¡ Key Features
### âœ” Patient-Specific PK Modeling
Inputs: age, sex, weight, Scr, dose, tau, number of doses  
Outputs: CrCl, CL, Vd, k, t1/2, Cmax_ss, Cmin_ss, exposure category

### âœ” Dual Digital Twin Comparison
Solid: patient  
Dashed: normal adult

### âœ” Explainable Clinical Interpretation  
Describes underexposure, accumulation, renal decline, dose needs.

### âœ” Fully Browser-Based  
No backend Â· No dependencies Â· Privacy-friendly

---

## ğŸ”¬ Scientific Background (Clinical PK)
| PK Factor | Normal Adult | Older Adult | Effect |
|----------|--------------|-------------|--------|
| CrCl | 80â€“120 mL/min | 30â€“50 mL/min | â†“ renal function |
| CL | 6â€“8 L/h | 3â€“4 L/h | â†“ 50% â†’ accumulation |
| Vd | 6â€“7 L/kg | 5â€“6 L/kg | â†“ lean mass |
| t1/2 | 36â€“48 h | 60â€“80 h | â†‘ 1.5â€“2Ã— |
| Cmin_ss | 0.4â€“0.7 ng/mL | 0.8â€“1.5 ng/mL | â†‘ toxicity |

References include findings from Jusko (1978), Koup (1980), Aronson, Brocks, Jelliffe.

---

## ğŸ›  Tech Stack
- HTML5 / CSS3 / Vanilla JS
- Chart.js
- Serverless client-side architecture

---

## ğŸš€ Getting Started

```bash
git clone https://github.com/yourusername/geriatric-digoxin-digitalTwin.git
cd geriatric-digoxin-digitalTwin
open version1.html   # or double-click
```

---

## ğŸ§© Versioned Modeling Assumptions

### ğŸ”¹ Version 1.0 â€” Educational PK Model
- One-compartment IV bolus
- Renal scaling:
  
CL = TV_CL Ã— (CrCl/80)^0.75
- Weight scaling:
  
V = TV_V Ã— (weight/70)
- Cockcroftâ€“Gault CrCl
- Steady-state via exponential decay summation
- Therapeutic range: 0.5â€“1.0 ng/mL  
**Limitations:** No IIV, no Bayesian updating, no distribution phase
  <img width="966" height="794" alt="image" src="https://github.com/user-attachments/assets/70f64dbd-0595-42c2-a43b-9a1e54a234ac" />


### ğŸ”¹ Version 2.0 â€” Mechanistic PopPK
- Two-compartment model
- PopPK covariate models
- Inter-individual variability
- Bayesian MAP updating
- 95% prediction intervals

### ğŸ”¹ Version 2.5 â€” Clinical Decision Module
- P-gp interactions  
- Electrolyte effects (K+, Mg2+, Ca2+)  
- Precision dosing engine  

---

## ğŸ“š Citation
1. Brocks DR. Pharmacokinetic Considerations for Digoxin in Older Adults. Drugs & Aging. 2012.
2. Aronson JK. Digoxin Pharmacokinetics in the Elderly. Br J Clin Pharmacol. 1980.
3. Koup JR, Jusko WJ. General Pharmacokinetic Model for Digoxin. J Pharmacokinet Biopharm. 1976.
4. Salcedo-Mingoarranz ÃL et al. Population Pharmacokinetics of Digoxin in Elderly Patients: A Systematic Review. Farm Hosp. 2022.
5. Zhou X et al. Population Pharmacokinetic Model of Digoxin in Older Chinese Patients. 2016.


Â© 2025 Goyeun Yun. All rights reserved.
